REGENXBIO Inc. (RGNX) Retained Earnings (Accumulated Deficit) USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
REGENXBIO Inc. quarterly Retained Earnings (Accumulated Deficit) history and growth rate from 2014 to 2024.
  • REGENXBIO Inc. Retained Earnings (Accumulated Deficit) for the quarter ending March 31, 2024 was -$768 M, a 51.2% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 -$768 M -$260 M -51.2% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$705 M -$263 M -59.7% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 -$642 M -$261 M -68.3% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$580 M -$274 M -89.6% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 -$508 M -$270 M -114% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 -$442 M -$280 M -174% Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$382 M +$73.6 M +16.2% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 -$306 M +$90.7 M +22.9% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 -$238 M +$101 M +29.9% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 -$161 M +$128 M +44.2% Dec 31, 2021 10-K 2023-02-28
Q3 2021 -$455 M -$212 M -87.5% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 -$397 M -$145 M -57.7% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 -$339 M -$121 M -55.7% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 -$289 M -$111 M -62.6% Dec 31, 2020 10-K 2022-03-01
Q3 2020 -$243 M -$91.5 M -60.4% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 -$252 M -$135 M -115% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 -$218 M -$103 M -88.9% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 -$178 M -$94.8 M -114% Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$151 M -$64 M -73.3% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 -$117 M -$48.7 M -71.4% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 -$115 M -$36.6 M -46.5% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 -$83 M +$105 M +55.8% Dec 31, 2018 10-K 2020-02-26
Q3 2018 -$87.3 M +$84.4 M +49.2% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 -$68.1 M +$82.9 M +54.9% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 -$78.7 M +$57.9 M +42.4% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 -$188 M -$73.2 M -63.9% Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$172 M -$76.8 M -80.8% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 -$151 M -$74.2 M -96.6% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 -$137 M -$74.2 M -119% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 -$115 M -$63 M -122% Dec 31, 2016 10-K 2018-03-06
Q3 2016 -$95 M -$48.5 M -105% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 -$76.8 M Jun 30, 2016 10-Q 2016-08-09
Q1 2016 -$62.4 M Mar 31, 2016 10-Q 2016-05-05
Q4 2015 -$51.6 M -$22.8 M -79.2% Dec 31, 2015 10-K 2017-03-07
Q3 2015 -$46.4 M Sep 30, 2015 10-Q 2015-11-05
Q4 2014 -$28.8 M Dec 31, 2014 10-K 2016-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.